BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Invitae to Present at Upcoming Investor Conferences - Feb 03, 2022

  Invitae Corporation, a leading medical genetics company, announced that members of its management team will participate in virtual fireside chats at the following investor conferences:

  February 3, 2022

   · 

  1 min read
• BioForest

  Gilead Sciences to Present at Upcoming Investor Conferences - Feb 03, 2022

  Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.

  February 3, 2022

   · 

  1 min read
• JCR Pharmaceuticals to Present at the 18th Annual WORLDSymposiumTM 2022

  JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that it will present six posters at the 18th Annual WORLDSymposiumTM 2022, to be held February 7-11, 2022 in San Diego, Calif.

  February 3, 2022

   · 

  11 min read
• BioForest

  Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), today announced that Silverback management will participate in the SVB Leerink 11th Annual Global Healthcare Conference.

  February 3, 2022

   · 

  1 min read
• Deals

  Sierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

  Sierra Oncology, Inc today announced that the underwriters of its previously announced underwritten public offering exercised in full their option to purchase 750,000 additional shares of common stock at a price of $27.00 per share.

  February 3, 2022

   · 

  2 min read
• Medtronic continuous glucose monitoring to be reimbursed for eligible Alberta youth living with diabetes

  Medtronic Canada ULC, a subsidiary of Medtronic plc, a global leader in healthcare technology, applauds the Alberta government’s announcement of a comprehensive reimbursement program for continuous glucose monitoring for eligible residents living with diabetes, under the age of 18.

  February 3, 2022

   · 

  4 min read
• Pharm Country

  Arvinas to Present at Upcoming Investor Conferences - Feb 03, 2022

  Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that it will participate in two upcoming virtual investor conferences.

  February 3, 2022

   · 

  1 min read
• Genetown

  Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences - Feb 03, 2022

  Monte Rosa Therapeutics, Inc., a biotechnology company developing novel molecular glue degrader medicines, announced that the company is scheduled to present at the following upcoming investor conferences:

  February 3, 2022

   · 

  1 min read
• Business

  Results of Single Center Study on Delcath’s CHEMOSAT® Hepatic Delivery System Published in Melanoma Research

  Delcath Systems, Inc. announces that results from a single-institution retrospective study, conducted by University Hospital Southampton NHS Foundation Trust (UHS) in England on the use of the Delcath CHEMOSAT® Hepatic Delivery System.

  February 3, 2022

   · 

  5 min read
• Biotech Bay

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 03, 2022

  Olema Pharmaceuticals, Inc. announced that the Company granted stock options to two new employees to purchase an aggregate of 270,000 shares of the Company’s common stock, effective as of February 1, 2022.

  February 3, 2022

   · 

  2 min read